Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma Cancer Cell International, 12 Oct 2022 Abstract Background Midazolam (MDZ) is an anaesthetic that is widely used for anxiolysis and sedation.
